Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

about

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

Item

http://www.wikidata.org/entity/Q47655922

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@en

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@nl

type

Item

label

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@en

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@nl

prefLabel

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@en

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@nl

P1476

Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

@en

P2093

A Baharani

http://www.w3.org/2001/XMLSchema#string

A Movseysan

http://www.w3.org/2001/XMLSchema#string

P Rajeev

http://www.w3.org/2001/XMLSchema#string

P2860

Bone turnover markers in primary hyperparathyroidism.

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study.

Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.

Primary hyperparathyroidism: pathophysiology and impact on bone.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.

The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.

A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop

P304

559-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1308/RCSANN.2017.0092

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28853593

http://www.w3.org/2001/XMLSchema#string

P921

hyperparathyroidism

P932

5697040

http://www.w3.org/2001/XMLSchema#string